Table 2.
Sepsis | No-sepsis | p value | |
---|---|---|---|
Age (years) | 49.1 ± 19.2 | 45.0 ± 18.2 | 0.210* |
Sex (% male) | 49.4% | 56.9% | |
Platelets (lakh/µL) | 2.61 ± 0.87 | 2.49 ± 1.13 | 0.49* |
SOFA score | 5.47 ± 2.91 | 4.74 ± 2.94 | 0.15* |
TLC (103/µL) | 9.91 ± 3.48 | 8.40 ± 3.05 | 0.01* |
IG# (103/µL) | 0.03 (0.01–0.06) | 0.03 (0.01–0.08) | 0.82# |
IG% | 0.3 (0.1–0.6) | 0.3 (0.1–0.8) | 0.34# |
Procalcitonin (ng/mL) | 0.54 (0.32–1.06) | 0.67 (0.34–1.54) | 0.34# |
Lactate (mmol/L) | 0.4 (0.3–0.7) | 0.5 (0.4–1.1) | 0.07# |
Age, platelet count, SOFA score, total leukocyte count (TLC) in mean ± S.D, and comparison by
Independent t-test. IG#, IG%, procalcitonin, lactate in median (interquartile range), and comparison by
Mann–Whitney U-test. Sepsis group included all patients by Sepsis-3 definition. No-sepsis group includes noninfectious organ dysfunction and controls